Comparison of the degenerative and inflammatory markers in cerebrospinal fluid in multiple sclerosis patients with relapsing-remitting course of disease and after clinically isolated syndrome

被引：0
|
作者：
Sladkova, Vladimira [1 ]
Mares, Jan [1 ]
Lubenova, Blanka [1 ]
Kollarova, Katarina [1 ]
Kanovsky, Petr [1 ]
机构：
[1] Univ Hosp Olomouc, Dept Neurol, Olomouc, Czech Republic
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S287 / S288
页数：2
相关论文
共 50 条
  • [31] Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis
    Beyer, Natascha Helena
    Lueking, Angelika
    Kowald, Axel
    Frederiksen, Jette Lautrup
    Heegaard, Niels H. H.
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 242 (1-2) : 26 - 32
  • [32] Apoptosis of cerebrospinal fluid lymphocytes in patients with relapsing-remitting, primary and secondary progressive multiple sclerosis
    Petelin, Z
    Brinar, V
    Zurak, N
    Dubravcic, K
    Botinic, D
    Ivankovic, D
    MULTIPLE SCLEROSIS JOURNAL, 2005, 11 : S125 - S126
  • [33] Clinically isolated syndromes and conversion to relapsing-remitting multiple sclerosis: a study on possible predictors, including cerebrospinal fluid oligoclonal IgM bands
    Ferraro, D.
    Simone, A. M.
    Bedin, R.
    Galli, V.
    Vitetta, F.
    Federzoni, L.
    D'Amico, R.
    Nichelli, P. F.
    Sola, P.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 242 - 242
  • [34] Stratification of relapsing-remitting multiple sclerosis patients by 2-DE analysis of cerebrospinal fluid
    Perga, S.
    Albo, A. Giuliano
    Lis, K.
    Minari, N.
    Reviglione, R.
    Falvo, S.
    Marnetto, F.
    Gilli, F.
    Capobianco, M.
    Malentacchi, M.
    Corpillo, D.
    Bertolotto, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S267 - S268
  • [35] Axonal damage markers in cerebrospinal fluid of patients with clinically isolated syndrome and early multiple sclerosis
    Tumani, H
    Petzold, A
    Brettschneider, J
    NEUROLOGY, 2006, 66 (05) : A94 - A94
  • [36] Consensus of opinion of US neurologists on practice patterns in clinically isolated syndrome and relapsing-remitting multiple sclerosis
    Tornatore, C.
    Phillips, J.
    Khan, O.
    Miller, A.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S283 - S283
  • [37] Benefit-Risk Analysis of Glatiramer Acetate for Relapsing-Remitting and Clinically Isolated Syndrome Multiple Sclerosis
    Qizilbash, Nawab
    Mendez, Ignacio
    Sanchez-de la Rosa, Rainel
    CLINICAL THERAPEUTICS, 2012, 34 (01) : 159 - 176
  • [38] Course of relapsing-remitting multiple sclerosis before, during and after natalizumab
    Kaufman, Michael D.
    Lee, R.
    Norton, H. J.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 (04) : 490 - 494
  • [39] Deep Gray Matter Atrophy in a Large Sample of Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis Patients
    Bergsland, Niels
    Dwyer, Michael G.
    Horakova, Dana
    Dolezal, Ondrej
    Havrdova, Eva
    Zivadinov, Robert
    NEUROLOGY, 2010, 74 (09) : A117 - A118
  • [40] Degenerative markers in cerebrospinal fluid in multiple sclerosis patients
    Sladkova, V.
    Mares, J.
    Lubenova, B.
    Kollarova, K.
    Opavsky, R.
    Kanovsky, P.
    JOURNAL OF NEUROLOGY, 2008, 255 : 82 - 83
12345